(19)
(11) EP 3 918 063 A1

(12)

(43) Date of publication:
08.12.2021 Bulletin 2021/49

(21) Application number: 19913048.5

(22) Date of filing: 31.01.2019
(51) International Patent Classification (IPC): 
C12N 15/10(2006.01)
C07K 16/00(2006.01)
C40B 40/02(2006.01)
C12N 7/00(2006.01)
C40B 30/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/00; C07K 16/005; C07K 16/244; C07K 16/248; C07K 16/2803; C07K 16/2818; C07K 16/2827; C07K 16/2878; C07K 2317/565; C07K 2317/622; C07K 2317/92; C12N 15/1062; C12N 2710/10343
(86) International application number:
PCT/US2019/016135
(87) International publication number:
WO 2020/159524 (06.08.2020 Gazette 2020/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: NantBio, Inc.
Culver City, California 90232 (US)

(72) Inventors:
  • OLSON, Clifford Anders
    Culver City, California 90232 (US)
  • NIAZI, Kayvan
    Culver City, California 90232 (US)

(74) Representative: Wichmann, Hendrik 
Wuesthoff & Wuesthoff Patentanwälte PartG mbB Schweigerstraße 2
81541 München
81541 München (DE)

   


(54) MRNA DISPLAY ANTIBODY LIBRARY AND METHODS